Lococerin 50mg Capsule contains Diacerein 50mg, an anthraquinone derivative used primarily for the management of osteoarthritis. Diacerein exerts its therapeutic effects by inhibiting interleukin-1 beta (IL-1β), a pro-inflammatory cytokine involved in cartilage degradation and inflammation in osteoarthritic joints. This mechanism helps reduce cartilage breakdown and alleviates symptoms such as joint pain and stiffness. Lococerin is indicated for patients with symptomatic osteoarthritis of the knee and other joints, providing both symptomatic relief and potential disease-modifying benefits. The capsule formulation ensures ease of administration and optimal bioavailability. It is generally prescribed as a part of a comprehensive treatment plan including physical therapy and lifestyle modifications. Common adverse effects may include mild gastrointestinal disturbances such as diarrhea, abdominal pain, or soft stools, which are usually transient. Caution is advised in patients with hepatic or renal impairment, and it is contraindicated in individuals with known hypersensitivity to Diacerein or its components. Regular monitoring of liver function tests is recommended during prolonged therapy. Lococerin should be used under medical supervision, and patients should be advised to report any unusual symptoms promptly. This medication offers a targeted approach to managing osteoarthritis symptoms while potentially slowing disease progression.